Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Trogarzo becomes available in the U.S.

May 2, 2018

Biktarvy granted positive opinion in Europe

April 30, 2018

Theratechnologies to seek European approval for Trogarzo based on available data

April 25, 2018

New phase II trial explores GS-9131 functional monotherapy in HIV-1 patients failing NRTI regimen

April 23, 2018

Novel genetically altered broadly neutralizing antibodies protect monkeys from SHIV

April 20, 2018

Gilead presents new compounds for HIV infection

April 17, 2018

Pharmacokinetics of anti-HIV agent GS-9131 explored in phase I study

April 3, 2018

NIAID initiates phase I study of HIV-1 vaccines

April 3, 2018

Mylan to introduce new triple combo once-daily HIV treatment in U.S.

March 29, 2018

Juluca receives positive opinion from EMA's CHMP

March 26, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026